Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R37 DK38842)
Received: 14 February 2021
Accepted: 21 April 2021
First Online: 1 May 2021
: An eIND was obtained from the FDA and all studies were performed with the approval of the Radiation Safety Committee for Human Use of Radiation (RSC1) and the Institutional Review Board. This statement is also included in the Patient Studies heading under Materials and Methods. Signed consent was obtained from each participant. This statement is also included in the Patient Studies heading under Materials and Methods.
: We consent for publication.
: Andrew T. Taylor and Raghuveer Halkar are entitled to a share of the royalties for the use of QuantEM™ software for processing MAG3 renal scans that was licensed by Emory University to GE Healthcare in 1993. They and their co-workers have subsequently developed a non-commercial, in house upgrade to the QuantEM™ software that was used in this study. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict of interest policies.